iqvia semaglutide tirzepatide prescriptions us q3 2024 Are Up, Health Services Utilization Down, and GLP-1s Are a Major Growth Driver: IQVIA's Update Obesity Deep Dive: The Unparalleled

Novo Nordisk, the maker of Ozempic, says it plans to study how the drug lowers a user's desire to drink alcohol

A smart scale with no watch is a fully supported combination, and the app's boards size themselves to whatever data you actually have

Its bound to happen, but there are ways to reduce the incidence and severity of them

Fertility treatments and multiple births in the United States

About Chris Chriss passion in life is helping others achieve their goals, improve their health and build the confidence that comes with feeling good about themselves

GLP-1 medications have a lower eligibility threshold, meaning more women qualify sooner